Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Fabhalta (iptacopan). Show all posts
Showing posts with label Fabhalta (iptacopan). Show all posts
Tuesday, July 23, 2024

FDA Approves Fabhalta (iptacopan) for the Treatment of Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)

›
Novartis announced the U.S. Food and Drug Administration (FDA) approval of  Fabhalta ®  (iptacopan) as the first oral monotherapy for the tr...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.